Tuesday,Regenxbio Inc. (RGNX) announced the appointment of Mitchell Chan as executive vice president and chief financial officer, effective September 17, 2024.
Chan takes over from Vit Vasista, who will remain with the Company as an advisor until January 3, 2025, to ensure a smooth transition.
Chan, a veteran finance executive, brings nearly 20 years of experience in the biotechnology sector, most recently as an Operating Partner at Catalio Capital Management. Before that, he held the position of CFO at Viela Bio.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.